LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors

NCT00019435 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Bladder Cancer
Breast Cancer
Colorectal Cancer
Esophageal Cancer
Gastric Cancer
Lung Cancer
Pancreatic Cancer

Interventions

BIOLOGICAL: LMB-9 immunotoxin

Sponsor

National Cancer Institute (NCI)